I have looked but could not see this paper having previously been mentioned.
Lyn did post this February 12 2019:
Survey re Clinical and Cost Effectiveness of Thyroid Drugs
healthunlocked.com/thyroidu...
This should not now be a research priority. It has only become one because of the failure to do the appropriate and necessary research from the 1950s through to now.
Exp Clin Endocrinol Diabetes
2019 Dec 9[Online ahead of print]
Management of Patients Symptomatically Unresponsive to Levothyroxine: Natural Desiccated Thyroid Extract or the Combination of Levothyroxine and Liothyronine? A Research Priority
Adrian Heald 1 2 , Mark Livingston 3 , Dyfrig Hughes 4
Affiliations
• PMID: 31820425
• DOI: 10.1055/a-1062-6167
Abstract
Around 5-10% of hypothyroid patients continue to experience profound and sometimes disabling symptoms, including fatigue, depression and impaired cognition, in spite of being adequately replaced biochemically. The use of the combination of levothyroxine and liothyronine and natural desiccated thyroid extract is controversial for reasons of costs, a lack of evidence of additional benefit over levothyroxine alone, and potential safety concerns. Clinical guidelines caution against the use of both, and advise that only in exceptional cases may a short trial be considered. Natural desiccated thyroid extract is not licensed for use in the UK. However, key deficiencies in the existing evidence-base together with improved understanding of the pharmacology of levothyroxine resistance, indicates that now is the right time for a definitive clinical trial to address this important area of uncertainty.
© Georg Thieme Verlag KG Stuttgart · New York.
Conflict of interest statement
The authors declare that they have no conflict of interest.